Nancy Hong - Profile and Investment Details

Investor Profile

Nancy Hong is a Venture Capital, Investor based in San Diego, California, United States with a diverse investment portfolio that includes companies such as Genoa Pharmaceuticals, Spruce Biosciences, OncoResponse, Lutonix, Standard Bariatrics, Smart Wires, Amplyx Pharmaceuticals, Arch Oncology, Venture Med Group, Auxeris Therapeutics, Kereos, Mirum PharmaceuticalsInterVene, Conforma Therapeutics, Tryton Medical, Salient Surgical Technologies, Adarza BioSystems, Excaliard Pharmaceuticals, MacroGenics, CardiaLen, Allakos, ZS Pharma, Accumetrics, Securus Medical Group, IDEV Technologies, Tioma Therapeutics, Reneo Pharmaceuticals, NexRay, Biolinq, Cabrellis Pharmaceuticals, Good Therapeutics, Xilio Therapeutics, Avalyn Pharma, Scout Bio, Lyric Pharmaceuticals, Calypso Medical, Velocimed, SeQure DX, Lumena Pharmaceuticals, Otonomy, Neuros Medical, . Over time, Nancy Hong has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Nancy Hong is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Music Venues, Events Services, Women Founded, Enterprise Software, Music, Life Science, Music Education, Education, Biotechnology, Video, Electronic Health Records (EHR), Health and Hospital Services, Clinical Trials, B2C, Health Diagnostics, Medical, Performing Arts, B2B, Therapeutics, Art, Pharmaceuticals, Nightlife may find it worthwhile to explore potential connections with Nancy Hong, as their portfolio suggests a familiarity and interest in this area.

Understanding Nancy Hong’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.